Skip to main content

Table 1 The main characteristics of the eligible literatures included in the meta-analysis

From: The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis

Study

Region

Tumor type

Sample size

TNM stage

FAM83H-AS1 expression

Cut-off value

Detection method

Outcome measure

NOS

High

Low

Arnes et al. [13]

United States

PDAC

49

NA

25

24

Median

qRT-PCR

OS

5

Baratieh et al. [14]

Iran

GC

74

I–IV

37

37

Median

qRT-PCR

OS

7

BRCA

382

NA

191

191

Median

qRT-PCR

OS

5

KIRP

72

NA

36

36

Median

qRT-PCR

OS

5

OC

184

NA

92

92

Median

qRT-PCR

OS

5

Bi et al. [9]

China

Glioma

187

I–IV

29

19

Median

qRT-PCR

OS

7

Da et al. [7]

China

GC

107

I–IV

53

54

Median

qRT-PCR

OS, DFS

7

Dou et al. [16]

China

OC

80

I–IV

38

42

Median

qRT-PCR

OS

7

Gong et al. [8]

China

OC

100

I–IV

48

52

Median

qRT-PCR

OS

7

Lu et al. [18]

China

CRC

62

I–IV

31

31

Median

qRT-PCR

OS

7

Ma et al. [21]

China

HCC

66

I–IV

32

34

Median

qRT-PCR

OS

7

Shan et al. [10]

China

BLCA

96

I–IV

48

48

Median

qRT-PCR

OS

7

Wang et al. [15]

China

GC

168

NA

84

84

Median

qRT-PCR

NA

6

Yang et al. [32]

China

CRC

87

I–IV

51

36

Median

qRT-PCR

OS

7

Yang et al. [17]

China

BRCA

837

I–IV

419

418

Median

qRT-PCR

OS

7

Yang et al. [19]

China

CRC

166

NA

83

83

Median

qRT-PCR

OS

5

Zhang et al. [20]

China

LC

101

I–III

51

50

Median

qRT-PCR

OS

7

  1. NA not available, DFS disease-free survival, OS overall survival, PDAC pancreatic ductal adenocarcinoma, GC gastric cancer, KIRP Kidney renal papillary cell carcinoma, OC ovarian cancer, CRC colorectal carcinoma, BLCA bladder cancer, HCC hepatocellular carcinoma, BRCA breast cancer, LC lung cancer